Human Physiology — Current Affairs 2026
Current Affairs Connections
CRISPR-based Gene Therapy Approved for Sickle Cell Disease in US and UK
Late 2023 - Early 2024The approval of Casgevy, a CRISPR-based gene therapy, for sickle cell disease and beta-thalassemia marks a monumental breakthrough in medical science. Sickle cell disease is a genetic disorder affecting red blood cells, leading to chronic pain, anemia, and organ damage due to abnormal hemoglobin. This therapy directly targets the genetic defect in hematopoietic stem cells, correcting the physiological malfunction at its source. From a physiological standpoint, it represents a shift from symptom management to curative intervention by restoring normal red blood cell function and oxygen transport capacity. This development highlights the growing potential of biotechnology [VY:SCI-04-02] to address fundamental physiological disorders.
UPSC Angle: GS-III (Science & Technology - Biotechnology, Health): Discuss the ethical implications of gene editing, the potential for treating other genetic disorders, and the accessibility challenges of such advanced therapies in developing countries. Connects to 'genetics and evolution mechanisms' [VY:SCI-03-01].
Advancements in AI for Early Detection of Cardiovascular Diseases
2024-2025 (Ongoing Research & Implementation)Artificial intelligence and machine learning algorithms are increasingly being deployed to analyze vast datasets from medical imaging (ECGs, echocardiograms, CT scans) and patient health records to predict the risk of cardiovascular diseases (CVDs) even before symptoms manifest. These AI models can identify subtle physiological markers and patterns that human clinicians might miss, leading to earlier diagnosis and intervention for conditions like atherosclerosis, heart failure, and arrhythmias. This technological integration is revolutionizing cardiac care by enhancing predictive accuracy and enabling personalized prevention strategies, thereby improving long-term physiological outcomes for patients.
UPSC Angle: GS-III (Science & Technology - AI, Health): Examine the role of AI in healthcare, its potential to transform diagnostics and treatment, data privacy concerns, and the need for robust regulatory frameworks for AI in medicine. Relevant for 'scientific research and development' [VY:SCI-01-03] and 'health policy and medical ethics' [VY:GOV-05-08].
WHO's New Guidelines for Diabetes Management Emphasize Integrated Care and Digital Health
2024The World Health Organization (WHO) has released updated guidelines for diabetes management, placing a strong emphasis on integrated care models, community-based interventions, and the leveraging of digital health technologies. Physiologically, diabetes mellitus involves a dysfunction in insulin production or action, leading to chronic hyperglycemia and systemic complications. The new guidelines advocate for continuous glucose monitoring (CGM), telemedicine for remote consultations, and AI-powered tools for dietary and lifestyle recommendations. This holistic approach aims to improve patient adherence, enhance glycemic control, and prevent long-term physiological damage to organs like kidneys, eyes, and the cardiovascular system, reflecting a global effort to manage a widespread endocrine disorder.
UPSC Angle: GS-II (Social Justice - Health, Government Policies) & GS-III (Science & Technology - Digital Health): Discuss the challenges of managing non-communicable diseases (NCDs) in India, the role of public health initiatives, the potential of digital health in improving access and outcomes, and the economic burden of diabetes on healthcare systems [VY:ECO-06-04].